NCT04282343

DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer

A Phase 2 Trial of the Discussion of Cost (DISCO) App as an Intervention to Improve Financial Outcomes in Hematologic Cancer Patients

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: Barbara Ann Karmanos Cancer Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This phase II trial studies how well the DIScussion of COst (DISCO) application (app) works in improving financial outcomes in patients with hematologic cancer. The DISCO app is an electronic, highly scalable and tailorable education and communication intervention that may help researchers learn more about improving how patients and oncologists discuss cancer treatment costs

Detailed description

PRIMARY OBJECTIVE: I. To assess the effectiveness of the DISCO app on prompting patient-oncologist treatment cost discussions during patient-physician interactions (as observed in video recordings), patient outcomes related to financial toxicity immediately after the patient-oncologist interaction, and at a 3-month follow up.

Conditions

• Chronic Lymphocytic Leukemia
• Chronic Myelogenous Leukemia, BCR-ABL1 Positive
• Plasma Cell Myeloma

Interventions

Type	Name	Description
BEHAVIORAL	The DISCO App	Patients will receive an individually-tailorable cancer treatment cost education and communication intervention delivered on an iPad just prior to meeting with their oncologist.
BEHAVIORAL	Usual Care	Patients randomized to this arm will receive usual care.

Timeline

• Start date: 2020-02-25
• Primary completion: 2022-10-21
• Completion: 2022-10-21
• First posted: 2020-02-24
• Last updated: 2023-05-03

Locations

1 site across 1 country: United States